Alnylam Pharmaceuticals | ALNY - 营业费用

金融业

USD 174.00

USD 7.99B

现金及等价物

USD 1.75B

USD 298.45M

USD 5.11B

USD 2.06B

USD 1.27B

USD 112.6M

USD 245.34M

2.23K

EPS每股收益

USD 16.26

股本和储备

USD 3.6B

USD 992.69M

债务利息支出

USD 82.05M

USD 28.14M

USD 2.47B

USD 23.91B

USD 164.49M

USD 1.06B

USD 112.6M

普通股股本

USD 133.73M

75.64

USD 177.81M

USD 1.46B

销售和管理费用

USD 347.92M

USD 105.91M

贸易债权人

USD 135.4M

应收帐款人

USD 912.74M

	营业费用	更改		日
Acadia Pharmaceuticals	USD 270.12M		2.55M	2026-06
Agios Pharmaceuticals	USD 130.77M		10.77M	2026-03
Alnylam Pharmaceuticals	USD 1.06B		160.97M	2026-06
Amgen	USD 11.69B		6.9B	2026-06
Arrowhead Research	USD 245.35M		30.35M	2026-06
BioCryst Pharmaceuticals	USD 119.78M		673.63M	2026-06
BioMarin Pharmaceutical	USD 6.32B		5.69B	2026-06
Incyte	USD 973.64M		4.65B	2026-06
Ionis Pharmaceuticals	USD 370.24M		6.24M	2026-06
Moderna	USD 960M		817M	2026-06
Neurocrine Biosciences	USD 739.1M		139.2M	2026-06
Novartis	USD 9.29B		507M	2026-03
PTC Therapeutics	USD 211.54M		15.12M	2026-06
Regeneron Pharmaceuticals	USD 31.71B		287.8M	2026-06
Sangamo BioSciences	USD 33.87M		12.89M	2024-06
Sanofi	EUR 8.98B		1.73B	2026-03
Sarepta Therapeutics	USD 387.96M		15.59M	2026-06
Takeda	JPY 981.78B		36.71B	2026-09
Tectonic Therapeutic	USD 27.3M		5.78M	2026-03
Ultragenyx Pharmaceutical	USD 289M		16M	2026-06
Vertex Pharmaceuticals	USD 2.07B		217.1M	2026-06
Xencor	USD 87.82M		5.44M	2026-06